Browsing by Author "Kearney, N"
Now showing 1 - 5 of 5
Results Per Page
Sort Options
- ItemEvaluation of a mobile phone-based, advanced symptom management system (ASyMS) in the management of chemotherapy-related toxicity.(2009-03-13) Kearney, N; McCann, L; Norrie, J; Taylor, L; Gray, P; McGee-Lennon, M; Sage, M; Miller, M; Maguire, ROBJECTIVES To evaluate the impact of a mobile phone based remote monitoring advanced symptom management system ASyMS on the incidence severity and distress of six chemotherapy related symptoms nausea vomiting fatigue mucositis hand foot syndrome and diarrhoea in patients with lung breast or colorectal cancer DESIGN A two group intervention and control by five time points baseline pre cycle 2 pre cycle 3 pre cycle 4 and pre cycle 5 randomised controlled trial SETTING Seven clinical sites in the UK five specialist cancer centres and two local district hospitals PARTICIPANTS One hundred and twelve people with breast lung or colorectal cancer receiving outpatient chemotherapy INTERVENTIONS A mobile phone based remote monitoring advanced symptom management system ASyMS MAIN OUTCOME MEASURES Chemotherapy related morbidity of six common chemotherapy related symptoms nausea vomiting fatigue mucositis hand foot syndrome and diarrhoea RESULTS There were significantly higher reports of fatigue in the control group compared to the intervention group odds ratio 2 29 95 CI 1 04 to 5 05 P 0 040 and reports of hand foot syndrome were on average lower in the control group odds ratio control intervention 0 39 95 CI 0 17 to 0 92 P 0 031 CONCLUSION The study demonstrates that ASyMS can support the management of symptoms in patients with lung breast and colorectal cancer receiving chemotherapy
- ItemInvolving health professionals in the development of an advanced symptom management system for young people: the ASyMS-YG study.(2009-08-03) Gibson, F; Aldiss, S; Taylor, R M; Maguire, R; Kearney, NPURPOSE OF THE STUDY ASyMS is an advanced symptom management system utilising mobile phone technology for patients to report cancer chemotherapy related symptoms The aim of this paper is to present health professionals involvement in the development of ASyMS for use with young people YG and evaluate their perceptions of the system STAGE 1 Health professionals reviewed the symptoms chosen by young people to be included on the personal digital assistant questionnaire to confirm they would have universal relevance These included mouth sores nausea diarrhoea vomiting and weight loss STAGE 2 Health professionals completed a questionnaire prior to the study commencing which suggested they felt ASyMS YG would give young people control and facilitate timely interventions when symptoms occur Post study perceptions were sought through semi structured interviews and consultation sessions with 23 health professionals These showed two over arching themes young people s symptoms and perceptions of ASyMS YG and six sub themes increased control for young people enhances communication between young people and health professionals and helps with professional early intervention increased support for young people improve knowledge and understanding technology appealing to young people CONCLUSIONS This early development work indicates that ASyMS YG is acceptable to health professionals and their perceptions of the system were overall very positive Health professionals will continue to be involved in the study through developing self care guidelines and alert system which will be tested in an exploratory trial stage 3 and randomised controlled trial stage 4 in the future
- ItemNurse's perceptions and experiences of using of a mobile-phone-based Advanced Symptom Management System (ASyMS) to monitor and manage chemotherapy-related toxicity.(2008-09-03) Maguire, R; McCann, L; Miller, M; Kearney, NMany people diagnosed with cancer will receive chemotherapy as a core component of their care Recent changes in the delivery of cancer services mean that patients frequently receive care on an out patient basis and are therefore often required to manage related side effects at home without direct support from oncology health professionals The use of information and communications technology may be seen as a means of supporting patients receiving chemotherapy in the home care setting This mixed methods study reports on the perceptions of nurses n 35 who participated in a randomised controlled trial of a mobile phone based Advanced Symptom Management System ASyMS in the management of chemotherapy related toxicity in patients with breast lung and colorectal cancer Nurses perceptions of ASyMS were evaluated at the start and the end of the study Overall they could see the benefits of ASyMS in the remote monitoring of chemotherapy toxicity and its role in facilitating early intervention and subsequent management demonstrating the potential utility of the system within clinical practice
- ItemPatients' perceptions and experiences of using a mobile phone-based advanced symptom management system (ASyMS) to monitor and manage chemotherapy related toxicity.(2009-03-09) McCann, L; Maguire, R; Miller, M; Kearney, NChemotherapy forms a core component of treatment for the majority patients with cancer Recent changes in cancer services mean patients frequently receive such treatment as outpatients and are often required to manage side effects at home without direct support from oncology health professionals Information technology continues to develop to support patients in the community this study evaluated the impact of a mobile phone based advanced symptom management system ASyMS on chemotherapy related toxicity in patients with lung breast or colorectal cancer One hundred and twelve patients were randomized from seven clinical sites across the UK 56 patients used the mobile phone to record their symptoms sending their reports directly to the nurses at their clinical site 56 control group patients received standard care Health professionals were alerted about any severe or life threatening symptoms through the development of a chemotherapy symptom risk model Patients perceptions of ASyMS were evaluated pre and post participation Patients reported many benefits of using ASyMS including improved communication with health professionals improvements in the management of their symptoms and feeling reassured their symptoms were being monitored while at home ASyMS has the potential to positively impact on the management of symptoms in patients receiving chemotherapy treatment
- ItemUtilising handheld computers to monitor and support patients receiving chemotherapy: results of a UK-based feasibility study.(2006-06-14) Kearney, N; Kidd, L; Miller, M; Sage, M; Khorrami, J; McGee, M; Cassidy, J; Niven, K; Gray, PGOALS OF WORK Recent changes in cancer service provision mean that many patients spend a limited time in hospital and therefore experience and must cope with and manage treatment related side effects at home Information technology can provide innovative solutions in promoting patient care through information provision enhancing communication monitoring treatment related side effects and promoting self care PATIENTS AND METHODS The aim of this feasibility study was to evaluate the acceptability of using handheld computers as a symptom assessment and management tool for patients receiving chemotherapy for cancer A convenience sample of patients n 18 and health professionals n 9 at one Scottish cancer centre was recruited Patients used the handheld computer to record and send daily symptom reports to the cancer centre and receive instant tailored symptom management advice during two treatment cycles Both patients and health professionals perceptions of the handheld computer system were evaluated at baseline and at the end of the project MAIN RESULTS Patients believed the handheld computer had improved their symptom management and felt comfortable in using it The health professionals also found the handheld computer to be helpful in assessing and managing patients symptoms CONCLUSIONS This project suggests that a handheld computer based symptom management tool is feasible and acceptable to both patients and health professionals in complementing the care of patients receiving chemotherapy